Cargando…
A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults
Objective: The purpose of the study was to evaluate the anti-aging effect of NMN and its safety in a double-blind, parallel, randomised controlled clinical trial. Methods: The study was carried out on 66 healthy subjects between the ages of 40 and65 years, instructed to take two capsules (each conta...
Autor principal: | Huang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261366/ https://www.ncbi.nlm.nih.gov/pubmed/35821806 http://dx.doi.org/10.3389/fragi.2022.851698 |
Ejemplares similares
-
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
por: Yi, Lin, et al.
Publicado: (2022) -
The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial
por: Chwiszczuk, Luiza Jadwiga, et al.
Publicado: (2023) -
Randomised, Double Blind, Placebo-Controlled Trial of Echinacea Supplementation in Air Travellers
por: Tiralongo, E., et al.
Publicado: (2012) -
Effect of selenium supplementation on musculoskeletal health in older women: a randomised, double-blind, placebo-controlled trial
por: Walsh, Jennifer S, et al.
Publicado: (2021) -
High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial
por: Mitsui, Jun, et al.
Publicado: (2023)